Supervisory Agency United States Food and Drug Administration (FDA) has recently issued a warning to the drugs used to prevent brittle bones or osteoporosis because it can increase the risk of fractures. The FDA added that all bisphosphonate drugs in this class must menyantumkan warning on the label that the drug has an unusual side effect.
For information, bisphosphonates be given to more than half a million patients in an effort to strengthen bones and reduce fracture risk. In the UK, only a bisphosphonate drug, alendronate that is suspected of including in the warning. However, authorities are still researching to make sure the truth.
Nearly three million people in the UK have osteoporosis. This causes the brittle bone condition is also about 230 thousand people suffer a fracture each year.